Home
About
FAQ
History (23)
The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies.
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.
Investigation of the safety effects of knee bolster air bag deployment in similar real-world crash comparisons.
Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
Definitions of measures of effect duration for psoriasis treatments.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Definitions of measures of effect duration for psoriasis treatments.
Gordon KB, Feldman SR, Koo JY, Menter A, Rolstad T, Krueger G. Definitions of measures of effect duration for psoriasis treatments. Arch Dermatol. 2005 Jan; 141(1):82-4.
View in:
PubMed
subject areas
Humans
Psoriasis
Terminology as Topic
Time Factors
Treatment Outcome
authors with profiles
Steven R. Feldman MD, PhD